Fed Food Pellets Research Articles

The Effects of Short- and Long-Term Ingestion of Plastic Toxin Bisphenol A on Gastrointestinal Transit Time in Rats.

Introduction Exposure to bisphenol A (BPA), a toxic chemical released from plastic, affects various body functions, including reproduction, metabolism, and development. The most common route of exposure to BPA is oral, and the gastrointestinal(GI) tract is, therefore, the first body system to be exposed to BPA. BPA has been well-documented to impair gut contractility in rats, in vitro. It may therefore be hypothesized that BPA may adversely affect GI motility and hence slow down the movement of food, resulting in the increased transit of food bolus in the GI tract. There are no reports so far on the effects of BPA on GI transit time. Objectives The present study was undertaken to examine the impact of exposure to BPA by a single oral dose (termed as short-term ingestion of BPA) and chronic (28-day) oral dose (termed as long-term ingestion of BPA) on the transit time of food bolus in the gut of adult male albino rats. Methods and materials The study was conducted in the Department of Physiology,Institute of MedicalSciences,Banaras Hindu University, Varanasi,Uttar Pradesh, India. In one set of experiments, each animal was fed a food pellet, once (short-term ingestion) containing BPA (2 µg/kg and 50 µg/kg in different groups), and in another set of experiments, each animal was fed a food pellet containing BPA (50 µg/kg/day) for 28 consecutive days (long-term ingestion). Control rats in both sets were fed food pellets without BPA. Subsequently, the gastric transit index (GTI), ileocecal transit index (ICTI), and colonic transit time (CTT) were determined by the standard charcoal marker method. Results One-time ingestion of a food pellet containing BPA caused a significant (p < 0.05) drop in the GTI and ICTI and an increase in the CTT with both doses of BPA (2 and 50 µg/kg). Similarly, after chronic (28-day), oral BPA exposure, a significant decrease in the GTI and ICTT and an increase in CTT were observed. Conclusion Both short-term (one-time) and long-term (28-day) oral exposure to BPA-containing food harmed GI transit. Slow GI transit may lead to metabolic disorders and GI motility disorders, such as constipation.

No evidence of spherical microplastics (10-300 μm) translocation in adult rainbow trout (Oncorhynchus mykiss) after a two-week dietary exposure.

The consumption of fish contaminated with microplastics is often cited as a pathway for human exposure. However, because their guts are generally removed before consumption, exposure may be low compared to other routes such as shellfish, drinking water and dust. Still, microplastics have been found to translocate from the gut to other tissues, making exposure from eating fish fillets or other seafood products a potential concern. To better understand fish as an exposure route for microplastics in humans, we tested hypotheses about whether translocation occurs and if efficiency of translocation is dependent on particle size. We investigated the amount and distribution of fluorescent polyethylene microspheres (10–300 μm) in the gut, liver, fillets and gonads of adult rainbow trout after a two-week dietary exposure. Fish were fed food pellets dosed with up to ~9,800 microspheres per gram of food. Total exposures over the entire experiment ranged from ~80,000–850,000 microspheres per fish. We did not find any particles in the fillets, liver, or gonads of any fish, suggesting that translocation of spherical microplastics of this size range does not occur in adult rainbow trout. The quantity of microplastics found in the gut was also low or absent after a 24-hour depuration period, indicating effective excretion in this laboratory population. This research suggests that the consumption of fish fillets may not be a significant exposure pathway for microspheres >10 μm in size to contaminate humans. Future studies should test for different sizes, morphologies and species to further our understanding.

Analyses of the possible anti-tumor effect of yokukansan.

The Kampo medicine yokukansan (YKS) has a wide variety of properties such as anxiolytic, anti-inflammatory and analgesic effects, and is also thought to regulate tumor suppression. In this study, we investigated the anti-tumor effect of YKS. We used Lewis lung carcinoma (LLC)-bearing mice that were fed food pellets containing YKS and then performed a fecal microbiota analysis, a microarray analysis for microRNAs (miRNAs) and an in vitro anti-tumor assay. The fecal microbiota analysis revealed that treatment with YKS partly reversed changes in the microbiota composition due to LLC implantation. Furthermore, a miRNA array analysis using blood serum showed that treatment with YKS restored the levels of miR-133a-3p/133b-3p, miR-1a-3p and miR-342-3p following LLC implantation to normal levels. A TargetScan analysis revealed that the epidermal growth factor receptor 1 signaling pathway is one of the major target pathways for these miRNAs. Furthermore, treatment with YKS restored the levels of miR-200b-3p and miR-200c-3p, a recognized mediator of cancer progression and controller of emotion, in the hypothalamus of mice bearing LLC. An in vitro assay revealed that a mixture of pachymic acid, saikosaponins a and d and isoliquiritigenin, which are all contained in YKS, exerted direct and additive anti-tumor effects. The present findings constitute novel evidence that YKS may exert an anti-tumor effect by reversing changes in the fecal microbiota and miRNAs circulating in the blood serum and hypothalamus, and the compounds found in YKS could have direct and additive anti-tumor effects.

Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer's Disease.

Yokukansan (YKS) is a traditional Japanese herbal medicine that has been used in humans for the treatment of several neurological conditions, such as age-related anxiety and behavioral and psychological symptoms (BPSD) related to multiple forms of dementia, including Alzheimer’s disease (AD). However, the cellular and molecular mechanisms targeted by YKS in the brain are not completely understood. Here, we compared the efficacy of YKS in ameliorating the age- and early-onset familial AD-related behavioral and cellular defects in two groups of animals: 18- to 22-month-old C57BL6/J wild-type mice and 6- to 9-month-old 5xFAD mice, as a transgenic mouse model of this form of AD. Animals were fed food pellets that contained YKS or vehicle. After 1–2 months of YKS treatment, we evaluated the cognitive improvements in both the aged and 5xFAD transgenic mice, and their brain tissues were further investigated to assess the molecular and cellular changes that occurred following YKS intake. Our results show that both the aged and 5xFAD mice exhibited impaired behavioral performance in novel object recognition and contextual fear conditioning (CFC) tasks, which was significantly improved by YKS. Further analyses of the brain tissue from these animals indicated that in aged mice, this improvement was associated with a reduction in astrogliosis, microglia activation and downregulation of the extracellular matrix (ECM), whereas in 5xFAD mice, none of these mechanisms were evident. These results show the differential action of YKS in healthy aged and 5xFAD mice. However, both aged and 5xFAD YKS-treated mice showed increased neuroprotective signaling through protein kinase B/Akt as the common mode of action. Our data suggest that YKS may impart its beneficial effects through Akt signaling in both 5xFAD mice and aged mice, with multiple additional mechanisms potentially contributing to its beneficial effects in aged animals.

POPs and Gut Microbiota: Dietary Exposure Alters Ratio of Bacterial Species.

Persistent organic pollutants (POPs) have been implicated in myriad human health problems, including cancer, neurologic, immunologic, and reproductive defects, among many other adverse health effects.1 New lines of research suggest that chronic dietary exposure to POPs may also contribute to obesity and type 2 diabetes.2 In this issue of EHP, researchers examine how one POP in particular—2,3,7,8 tetrachlorodibenzofuran (TCDF)—affects the composition of the mouse gut microbiome.3 They report that TCDF exposure alters the gut microbiome in ways that may prove to contribute to obesity and other metabolic diseases. TCDF binds the aryl hydrocarbon receptor (AHR), which activates a variety of biological responses.1 Recent studies indicate that keeping the gut in good working order is one of these functions.4 Scanning electron microscope images show dense networks of bacteria in the small intestines of control mice (top), which were dramatically depleted in the small intestines of TCDF-treated mice (bottom). The gut microbiome is increasingly being recognized as influential in multiple aspects of health. “We’ve been focused on how POPs impact the host. Now we’re starting to see how these chemicals may impact the gut bacteria, either positively or negatively,” says study leader Andrew Patterson, an assistant professor of molecular toxicology at Pennsylvania State University. For five days, Patterson’s team fed food pellets spiked with 24 µg/kg TCDF to adult male mice that either carried or lacked the AhR gene. This helped to confirm that the AHR truly is involved in regulating the end points measured, including fluctuations in gut microbe populations, liver enzymes, and bile acids. Mice that lacked the AhR gene underwent marked changes in their gut microbial populations, with a decrease in Firmicutes species and an increase in Bacteroides species. These changes were associated with significantly increased levels of bile acids and short-chain fatty acids, altered liver function, increased intestinal inflammation, and inhibited signaling of the farnesoid X receptor, a key regulator of fat and glucose metabolism.3 The mice received a very high dose of TCDF, equivalent to 3,000 ng/kg in people.3 That’s about 1,000 times more than most adults are thought to ingest each day through food5 but in the range of high-dose industrial exposures.6 The researchers chose this high dose to ensure they would find observable changes and end points to pursue further. Now they’re feeding mice lower chronic doses of TCDF, and according to Patterson, preliminary data are showing similar changes as those seen at higher TCDF doses. Patterson’s results “show significant changes in the gut microbiome profile after TCDF administration, and they raise very interesting and important questions. But exactly what that means downstream needs more work to answer,” says Stephen Safe, a distinguished professor of toxicology at Texas A&M University, who was not involved with the study. The results add to mounting evidence that changes in the gut microbiome modulate many different diseases, Safe says. The results also contribute to the growing evidence that the gut microbiome is an important, although still not fully understood, player in the toxicity of environmental pollutants, says Michal Toborek, a professor and vice chair for research at the University of Miami Miller School of Medicine. Toborek previously reported in EHP that high doses of polychlorinated biphenyls, another type of POP, altered the composition of the gut microbiome in mice but that exercise appeared to blunt this effect.7

Dietary cadmium and benzo(a)pyrene increased intestinal metallothionein expression in the fish Fundulus heteroclitus

Fish were individually fed food pellets containing cadmium, benzo(a)pyrene, or a combination of the two, then analyzed for metallothionein mRNA expression in the intestine, liver, and gill using real-time RT-qPCR. An initial experiment using only cadmium showed that ingestion of pellets varied in individual fish, and estimates of cadmium dose from the numbers of ingested pellets indicated considerable individual variability in cadmium dose. Induction of intestinal metallothionein mRNA was apparent, however, and a linear dose–response relationship was observed for metallothionein expression and cadmium dose in the intestine, but not the other organs, which showed no induction. In a second experiment, the entire daily cadmium dose was provided in a single contaminated pellet that was consumed by all treated fish, effectively eliminating the effect of variable ingestion rates on dose, and the interaction between cadmium and benzo(a)pyrene was also investigated. The intestine was again the primary organ for metallothionein induction by cadmium. When benzo(a)pyrene was administered together with cadmium, induction of metallothionein was potentiated by the presence of benzo(a)pyrene, with the main effect seen in the intestine, where already high levels of induction by cadmium alone increased by 1.74-fold when benzo(a)pyrene was present.

Protection of Penaeus monodon against white spot syndrome virus by oral vaccination.

White spot syndrome virus (WSSV) occurs worldwide and causes high mortality and considerable economic damage to the shrimp farming industry. No adequate treatments against this virus are available. It is generally accepted that invertebrates such as shrimp do not have an adaptive immune response system such as that present in vertebrates. As it has been demonstrated that shrimp surviving a WSSV infection have higher survival rates upon subsequent rechallenge, we investigated the potential of oral vaccination of shrimp with subunit vaccines consisting of WSSV virion envelope proteins. Penaeus monodon shrimp were fed food pellets coated with inactivated bacteria overexpressing two WSSV envelope proteins, VP19 and VP28. Vaccination with VP28 showed a significant lower cumulative mortality compared to vaccination with bacteria expressing the empty vectors after challenge via immersion (relative survival, 61%), while vaccination with VP19 provided no protection. To determine the onset and duration of protection, challenges were subsequently performed 3, 7, and 21 days after vaccination. A significantly higher survival was observed both 3 and 7 days postvaccination (relative survival, 64% and 77%, respectively), but the protection was reduced 21 days after the vaccination (relative survival, 29%). This suggests that contrary to current assumptions that invertebrates do not have a true adaptive immune system, a specific immune response and protection can be induced in P. monodon. These experiments open up new ways to benefit the WSSV-hampered shrimp farming industry.

Scurvy in capybaras bred in captivity in Argentine.

In order to determine if the absence of vitamin C in the diet of capybaras (Hydrochoerus hydrochaeris) causes scurvy, a group of seven young individuals were fed food pellets without ascorbic acid, while another group of eight individuals received the same food with 1 g of ascorbic acid per animal per day. Animals in the first group developed signs of scurvy-like gingivitis, breaking of the incisors and death of one animal. Clinical signs appeared between 25 and 104 days from the beginning of the trial in all individuals. Growth rates of individuals deprived of vitamin C was considerably less than those observed in the control group. Deficiency of ascorbic acid had a severe effect on reproduction of another population of captive capybaras. We found that the decrease in ascorbic acid content in the diet affected pregnancy, especially during the first stages. The results obtained suggest that it is necessary to supply a suitable quantity of vitamin C in the diet of this species in captivity.

Amelioration of hyperlipidemia by low fat diets in chronically streptozotocin-diabetic rats

The effects of reduced dietary fat intake on plasma lipid levels were examined in diabetic rats. One week after induction of diabetes (D) with streptozotocin (65 mg/kg, iv), the animals were fed food pellets consisting of 1.5% (D 1.5), 2.5% (D 2.5) or 5% (D 5) fat for two weeks. Irrespective of the diets, both food and water consumed by untreated diabetic rats were 2- to 5-fold greater respectively compared to normal. Plasma glucose concentrations were also similarly increased. Plasma and skeletal muscle lipid levels were significantly greater than controls in D 2.5 and D 5, but not in the D 1.5 group. Plasma and muscle lipid concentrations correlated directly with fat consumption. In D 5 rats receiving insulin treatment, plasma glucose and lipid concentrations were comparable to control values. These findings indicate that the degree of hyperlipidemia in chronically diabetic rats is directly related to dietary fat intake. They also demonstrate that dietary interventions can modulate some of the metabolic abnormalities in diabetes.

Effects of food temperature and ambient temperature during a meal on food intake in the rat

Rats kept either at thermoneutrality (29°C) or in the cold (19°C) were fed either at thermoneutrality or in the cold. Rats kept in the cold ingested consistently more food than rats kept at thermoneutrality. Also, independently of nurture temperature, rats fed in the cold ingested more food than rats fed at thermoneutrality. There was no interaction between nurture temperature and meal temperature. In a second experiment, rats kept at thermoneutrality were fed food pellets previously warmed or cooled to 12, 29, or 48°C. Food temperature per se had no significant effect on food intake.